ACE2 and COVID-19: The major components not only have good binding ability with ACE2, but also effectively bind to the contact surface of ACE2 and the spinous process complex, thus playing a potential therapeutic role in COVID-19.[12,13] Therefore, this study intends to evaluate the safety and safety efficacy of LHQW in COVID-19 patients through systematic reviews and meta-analysis.